Oil, Gas and Consumable Fuels
Company Overview of Solazyme, Inc.
Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blendstocks for marine, motor vehicle, and jet fuels, as well as replacements for petrochemicals, oleochemicals, and functional fluids. It also provides fuels, including SoladieselBD and SoladieselRD for on-road applications; ultra-low sulfur diesel; and Solajet for aviation use. In addition, the company offe...
225 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2003
Key Executives for Solazyme, Inc.
Co-Founder, Chief Executive Officer and Director
Total Annual Compensation: $560.0K
Chief Financial Officer and Chief Operating Officer
Total Annual Compensation: $410.4K
Senior Vice President, General Counsel and Corporate Secretary
Total Annual Compensation: $335.0K
Chief Technology Officer
Total Annual Compensation: $370.8K
Total Annual Compensation: $378.8K
Compensation as of Fiscal Year 2014.
Solazyme, Inc. Key Developments
Kahn Swick & Foti, LLC and KSF Partner File Securities Class Action Lawsuit Against Solazyme, Inc
Aug 8 15
Kahn Swick & Foti, LLC and KSF partner filed securities class action lawsuit against Solazyme, Inc. Solazyme and certain of its executives are charged with failing to disclose material information during the class period and in connection with the March 27, 2014 Offerings, violating federal securities laws. Solazyme allegedly made false statements and omissions about its construction progress, development and production capacity at its renewable oils production facility located in Moema, Brazil, failing to disclose that the Moema Facility was experiencing construction delays due to insufficient access to electricity and steam utility services, and that these challenges would prohibit the Moema Facility from scaling its capacity production as projected. On November 5, 2014, the truth regarding the Moema Project was revealed to investors, and the price of Solazyme’s shares plummeted by 58%.
Solazyme, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015
Jul 30 15
Solazyme, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenues of $11,740,000 against $15,939,000 a year ago. Loss from operations was $26,318,000 against $32,232,000 a year ago. Net loss was $37,171,000 against $42,917,000 a year ago. Basic and diluted net loss per share was $0.46 against $0.56 a year ago. Net loss (non-GAAP) was $31,717,000 against $32,874,000 a year ago. Net loss per share (non-GAAP) - basic and diluted was $0.40 against $0.43 a year ago.
For the six months, the company reported total revenues of $24,345,000 against $28,330,000 a year ago. Loss from operations was $52,629,000 against $64,673,000 a year ago. Net loss was $71,836,000 against $77,598,000 a year ago. Basic and diluted net loss per share was $0.90 against $1.07 a year ago. Net loss (non-GAAP) was $61,250,000 against $63,402,000 a year ago. Net loss per share (non-GAAP) - basic and diluted was $0.77 against $0.87 a year ago. The year over year decline in Revenue was due to expected decreases in funded program revenue as well as in product revenue due to the timing of certain Algenist sales activities and slower than anticipated adoption rates for Encapso.
BASF and Solazyme, Inc Announces Launch the First Commercial Microalgae-Derived Betaine Surfactant
Jul 28 15
BASF and Solazyme, Inc. announced the launch of the first commercial surfactant derived from microalgae oil, a high performance algal betaine for use in home and personal care applications. Commercialized by BASF under the trade name Dehyton® AO 45, algal betaine is a betaine surfactant made from renewable microalgae oil. The new algal betaine is a high- performance alternative to amidopropyl betaine in products that require rich and gentle foam such as shampoos, liquid soaps, hand dishwashing liquids, and other applications. Amidopropyl betaines are amphoteric surfactants increasingly used in cosmetic, toiletry and home care applications due to their vast benefits and are known to have: good detergency, good foam properties and foam stabilization, hard water compatibility, mildness to skin and hair, ability to reduce irritation of anionic systems, viscosity building, conditioning effect, stability at a broad range of pH, and excellent biodegradability. Dehyton® AO 45 is produced with Solazyme AlgaPur™ Microalgae Oils. AlgaPur™ Oils are produced with Solazyme’s technology in a matter of days, using a highly controlled fermentation process to convert sugarcane into oils of the high purity and performance. AlgaPur™ Microalgae Oils are produced with low carbon, water and land use impact.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|